IP Library › Granted Patent US 12,622,782
Granted Patent B2
US 12,622,782 · App. 18/050,437 · Granted May 12, 2026

Prosthetic device for implantation in the aortic valve region of a heart

Inventors: Maximilian Kuetting (Gaertringen, DE); Steffen Westermann (Herrenberg, DE)
Assignee: NVT AG
A61F2/246A61F2/2412
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,622,782
App. No.
18/050,437
Granted
May 12, 2026
Kind
B2
Abstract

The present invention relates to a prosthetic device for deployment in the native aortic valve region of a heart, comprising a tubular spacer element, the spacer element being configured for placement within the native aortic valve region of a heart without contacting to the native aortic annulus; the prosthetic device further comprises at least one anchoring element designed for anchoring the prosthetic device within the heart, and at least one connecting element, coupling the spacer element to the at least one anchoring element; in the prosthetic device, the tubular spacer element further comprises a coaptation skirt element being connected to the outer surface of the spacer element, such, that the coaptation skirt element is inflatable during diastole.

Claims (28)

1 . A prosthetic device for deployment in the native aortic valve region of a heart, the native aortic valve region comprising the native aortic valve having a native annulus and native valve leaflets, the prosthetic device comprising:

a tubular spacer element comprising an outer surface, an inner surface, a length, a proximal inflow end, a distal outflow end and a lumen defined there between, the spacer element being configured for placement within the native aortic valve region of a heart without contacting to the native aortic annulus, and comprising a valve element being attached within the lumen to the spacer element's inner surface at the proximal inflow end;

at least one anchoring element, wherein the anchoring element is spatially separate from the tubular spacer element, and wherein the anchoring element is designed for and capable to anchor the prosthetic device within the native aortic valve region of a heart; and

at least one connecting element, coupling the spacer element to the at least one anchoring element, such, that spacer element is co-axially aligned and suspended inside the native aortic valve without contact to the aortic annulus,

wherein

the tubular spacer element comprises a coaptation skirt element, having a distal end and proximal end, the coaptation skirt element being attached, solely via its distal outflow end and its proximal inflow end, to the outer surface of the spacer element, such, that the portion between the proximal and distal end of the coaptation skirt element is not fixedly attached to the outer surface of the tubular spacer element, and that the coaptation skirt element is inflatable during diastole, such, that the coaptation skirt element, with the portion not fixedly attached to the outer surface of the spacer element is detached from the outer surface during diastole in a ballon-like fashion.

2 . The prosthetic device of claim 1 , wherein the coaptation skirt element, starting from the proximal inflow end of the spacer element, circumferentially covers the spacer element's outer surface up to 30%, 40%, 50%, 60%, 70%, 80%, 90%, or up to 100%.

3 . The prosthetic device of claim 1 , wherein the coaptation skirt element comprises or consists of a material selected from the group of biocompatible artificial material or biocompatible natural material, and in particular is selected from human or animal pericardium, polytetrafluoroethylene (PTFE), polyurethane and polyester.

4 . The prosthetic device of claim 1 , wherein the tubular spacer element comprises or consists of a tubular stent frame, and has a cross section that is selected from substantially round, oval, and triangular.

5 . The prosthetic device of claim 1 , wherein the anchoring element consists of a cylindrical stent element.

6 . The prosthetic device of claim 1 , wherein the anchoring element consists of a cylindrical stent element, and that the at least one connecting element consists of one or more singular non-tubular, straight flexible connecting element, the connecting element comprising a first end, a second end and a length extending there between, wherein the connecting element, via its respective first end is coupled to the spacer element, and, via its respective second end, is coupled to the anchoring element, wherein the length of the connecting elements is such, that when the anchoring element is placed downstream of the coronary arteries, the spacer element is suspended within the native aortic valve region of the heart without contacting to the native aortic annulus.

7 . The prosthetic device of claim 1 , wherein the anchoring element consists of a cylindrical stent element, and that the at least one connecting element consists of one or more singular non-tubular, curved flexible connecting element, the connecting element comprising a first end, a second end and a length extending there between, wherein the connecting element via its respective first end is coupled to the spacer element, and, via its respective second end, is coupled to the anchoring element, wherein the length and shape of the connecting elements is such, that when the anchoring element is placed in the aortic root, the spacer element is suspended within the native aortic valve region of the heart without contacting to the native aortic annulus.

8 . The prosthetic device of claim 1 , wherein the at least one connecting elements consist of one or more U-shaped lengthy attachment arm elements, the attachment arm elements comprising a first end, a second end and a length extending there between, wherein the attachment arm elements, via its respective first end is coupled to the spacer element, and, at its respective second end, comprises the at least one anchoring element, wherein the anchoring element consists of attachment means for anchoring the device in tissue surrounding the native aortic annulus, the attachment means being selected from one or more of a hook, a spike or an arrow.

9 . The prosthetic device of claim 1 , comprising a combination of one or more of the following anchoring elements (i) to (iii):

(i) an anchoring element consisting of a cylindrical stent element;

(ii) an anchoring element consisting of a cylindrical stent element, and the at least one connecting element consisting of one or more singular non-tubular, straight flexible connecting element, the connecting element comprising a first end, a second end and a length extending there between, wherein the connecting element, via its respective first end is coupled to the spacer element, and, via its respective second end, is coupled to the anchoring element, wherein the length of the connecting elements is such, that when the anchoring element is placed downstream of the coronary arteries, the spacer element is suspended within the native aortic valve region of the heart without contacting to the native aortic annulus;

(iii) an anchoring element consisting of a cylindrical stent element, and the at least one connecting element consisting of one or more singular non-tubular, curved flexible connecting element, the connecting element comprising a first end, a second end and a length extending there between, wherein the connecting element via its respective first end is coupled to the spacer element, and, via its respective second end, is coupled to the anchoring element, wherein the length and shape of the connecting elements is such, that when the anchoring element is placed in the aortic root, the spacer element is suspended within the native aortic valve region of the heart without contacting to the native aortic annulus.

10 . A method for treating aortic valve regurgitation, the method comprising the steps of

providing the prosthetic device of claim 1 , and

deploying the prosthetic device in the aortic valve region of a heart in a patient in need thereof in order to replace in its function or support the native aortic valve of said patient.

11 . A method for treating aortic valve regurgitation the method comprising the following steps:

providing the prosthetic device of claim 1 , the device comprising a stent element as anchoring element,

introducing the prosthetic device in the aortic valve region of a heart of a patient in need of treatment,

deploying the anchoring element downstream of the coronary arteries, preferably in the ascending aorta, thereby suspending the spacer element inside the native aortic annulus.

12 . A method for treating aortic valve regurgitation the method comprising the following steps:

providing the prosthetic device of claim 1 , the prosthetic device comprising a stent element as anchoring element,

introducing the prosthetic device in the aortic valve region of a heart of a patient in need of treatment,

deploying the anchoring element in the aortic root behind native aortic leaflets, i.e. upstream of the coronary arteries, thereby suspending the spacer element inside the native aortic annulus.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2022
From: KUETTING, MAXIMILIAN; WESTERMANN, STEFFEN
To: NVT AG
Reel/Frame 061964/0068 →
Priority Claims (1)
DE 10 2020 111 681.0 · Apr 29, 2020 · national
Continuity (2)
Continuation PCTEP2021060330 · Apr 21, 2021
Related Publication 20230068697A1 · Mar 2, 2023
References Cited (15)
US 9839513B2 · Essinger et al. · 2017 [cited by applicant]
US 11147667B2 · Yohanan · 2021 [cited by examiner]
US 12514699B2 · Morin · 2026 [cited by examiner]
US 20140277417A1 · Schraut · 2014 [cited by examiner]
US 20140350660A1 · Cocks · 2014 [cited by examiner]
US 20250161035A1 · Levi · 2025 [cited by examiner]
US 20250248810A1 · Shitrit · 2025 [cited by examiner]
EP 2149349 · 2010 [cited by applicant]
WO WO2009045331 · 2009 [cited by applicant]
WO WO2012048035A2 · 2012 [cited by examiner]
WO WO2013178335 · 2013 [cited by applicant]
WO WO2021219453 · 2021 [cited by applicant]
International Search report for International Application No. PCT/EP2021/060330, mailed Aug. 2, 2021, in 12 pages. [cited by applicant]
Written Opinion for International Application No. PCT/EP2021/060330, mailed Aug. 2, 2021. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/EP2021/060330, mailed Nov. 10, 2022. [cited by applicant]